David P. Brooks

N-((1 S)-1-{[4-((2 S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I

Kevin S. Thorneloe, Anthony C. Sulpizio, Zuojun Lin et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 400 citations

Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis

Eugene T. Grygielko, W. Martin, Christopher Tweed et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 186 citations

Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.

Y. Ouchi, Leonard Share, Joan T. Crofton et al. · Hypertension · 1987 · 147 citations · Full text

Hypertension, Reproductive Biology, Doc-salt Hypertension +16

Cloning and Functional Characterization of a Sodium-Dependent Phosphate Transporter Expressed in Human Lung and Small Intestine

John A. Feild, Li Zhang, Kimberly A. Brun et al. · Biochemical and Biophysical Research Communications · 1999 · 141 citations

Molecular Pharmacology, Signal Transduction, Molecular Physiology +11

Inhibition of Sympathetic Outflow by the Angiotensin II Receptor Antagonist, Eprosartan, but Not by Losartan, Valsartan or Irbesartan: Relationship to Differences in Prejunctional Angiotensin II Receptor Blockade

Eliot H. Ohlstein, David P. Brooks, Giora Feuerstein et al. · Pharmacology · 1997 · 118 citations

Hypertension, Angiotensin Ii, Neurophysiology +15